問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2024-02-21

林昌霖
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2020-03-31 - 2028-01-27

Phase II/III

Active
A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis
  • Condition/Disease

    Ulcerative Colitis

  • Test Drug

    Guselkumab/placebo

Participate Sites
4Sites

Recruiting4Sites